2023
The Case | A benign reason behind a malignant finding. Kidney Int. 2023;103(2):433-434.
Evolution of acquired resistance in a ROS1+ KRAS G12C+ NSCLC through the MAPK pathway. NPJ Precis Oncol. 2023;7(1):9.
Insulin feedback is a targetable resistance mechanism of PI3K inhibition in glioblastoma. Neuro Oncol. 2023;25(12):2165-2176.
Immunogenomic Landscape of Neuroendocrine Prostate Cancer. Clin Cancer Res. 2023;29(15):2933-2943.
PI-RADS 3 score: A retrospective experience of clinically significant prostate cancer detection. BJUI Compass. 2023;4(4):473-481.
EUS-guided liver biopsy using a novel hydrostatic stylet technique. VideoGIE. 2023;8(3):104-106.
"Stromal cells in prostate cancer pathobiology: friends or foes?". Br J Cancer. 2023;128(6):930-939.
Investigation into the genetics of fetal congenital lymphatic anomalies. Prenat Diagn. 2023;43(6):703-716.
Hyaluronan driven by epithelial aPKC deficiency remodels the microenvironment and creates a vulnerability in mesenchymal colorectal cancer. Cancer Cell. 2023;41(2):252-271.e9.